Early studies showed that several lymphoma-associated oncogenes bore mutations with the hallmark of SHM [21–23], and the molecular contribution of AID activity to off-target SHM was directly shown in mice later [20,24], indicating that a relatively high proportion of genes can be targets of AID mutagenic activity. This evidence concerns the gene AICDA and lymphoma.